New York City-based New York Gastroenterology Associates has announced a collaboration with medical data platform Lynx.MD.
Category: ROOT
The telemedicine backgrounds patients prefer
A University of Michigan study found that on telemedicine calls, a physician’s background impacts how the patient perceives the provider — with most patients preferring a physician office background.
Expert warns about healthcare's cybersecurity weakness
A cybersecurity expert said that the ransomware attacks on Change Healthcare and St. Louis-based Ascension has highlighted the healthcare industry’s cybersecurity weakness, CNN reported May 15.
Ohio system governance changes cause leadership disputes
Two pastors at Chillicothe, Ohio-based Adena Health System walked out of a May 14 pastor meeting due to disagreements over the governance structure at the health system.
Indiana physician pleads guilty to Medicaid fraud, obstruction of justice
A Muncie, Ind. physician has pleaded guilty to Medicaid fraud, among other charges, Muncie Star Press reported May 14.
Gastroenterology groups getting snapped up: 5 deals to know
Gastroenterology groups are continuing to get bigger — at least 108 gastroenterology practices consolidated between 2019 and 2023 and more than 12 gastroenterology companies expanded their footprint in 2023.
How Epic names its programs
Epic makes sure its product names have a “feeling” and require some thought for people to deduce the meaning, according to founder and CEO Judy Faulkner.
Mayo, Mercy collaborate to harness data for improved patient care
Rochester, Minn.-based Mayo Clinic and St. Louis-based Mercy are working together to examine de-identified patient data in a bid to find new methods for diagnosing, treating and preventing diseases.
Nurses call for pause on healthcare AI
Nurses around the country continue to raise their concerns about artificial intelligence use in healthcare, with the country’s biggest nursing union calling for a pause on the technology.
Walgreens to sell generic naloxone
Walgreens will sell a low-cost, over-the-counter version of the opioid overdose antidote naloxone, the company said May 15.
